Human papillomavirus E4 protein (E4 protein)

The Human papillomavirus E4 protein is a viral non-structural protein abundantly expressed during the productive stage of the HPV life cycle, especially in lesions caused by high-risk HPV types such as HPV16 and HPV18[2][5]. It is translated from a spliced mRNA comprising sequences from the E1 and E4 open reading frames[5][7]. Notably, E4 is unique among HPV proteins for its massive accumulation in infected epithelial cells—sometimes representing up to 30% of total protein content in lesions[5]. Functionally, E4 modulates the host cell environment to facilitate effective viral genome amplification and release: - It forms amyloid-like fibers that interact with and reorganize the keratin cytoskeleton, compromising epithelial cell mechanical integrity and possibly promoting virus release[1][3][6]. - E4 can arrest infected cells in G2 phase, supporting viral DNA replication but inhibiting cell division, with specific truncated forms exerting stronger G2 arrest[2][4]. - E4 expression serves as a highly specific, sensitive marker for productive HPV infection and correlates with disease severity in premalignant and malignant lesions[5][3]. - The protein is post-translationally modified (e.g., phosphorylation by MAPK family kinases and cleavage by calpain) to modulate its multimerization, keratin binding, and functional roles as the infected cell progresses through the cell cycle[3][6]. Although E4's detailed molecular mechanism remains under investigation and varies by HPV type, it is clear that E4 is not essential to the virus life cycle but substantially enhances viral genome replication efficiency and life cycle completion, particularly in high-risk types[2][5]. No drugs currently target E4 directly, but its diagnostic role as a biomarker is well-established in clinical and research settings[5][3].

Other names

HPV E4 proteinE1^E4 proteinPapillomavirus E4

Not applicable, as there are currently no drugs targeting E4 directly